• Explore /
  • Poster
  • / Serum neuroendocrine (NE) markers and clinical characteristics of treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) in men with metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.

Serum neuroendocrine (NE) markers and clinical characteristics of treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) in men with metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.

Abstract Poster

Authors

null

Rahul Raj Aggarwal

UC San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Rahul Raj Aggarwal , Li Zhang , Tomasz M. Beer , Jack Youngren , Alise Stromlund , Alexander Bell , Adam Foye , Denise Playdle , Joshi J. Alumkal , Robert Evan Reiter , Martin Gleave , Christopher P. Evans , George V. Thomas , Jiaoti Huang , Lawrence D. True , Matthew Rettig , Primo Lara Jr., Kim N. Chi , Eric Jay Small

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02432001

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr 278)

DOI

10.1200/JCO.2018.36.6_suppl.278

Abstract #

278

Poster Bd #

N10

Abstract Disclosures

Similar Posters

First Author: Morgan Goujon

First Author: Ulka N. Vaishampayan

First Author: Manish Kohli

Poster

2014 Genitourinary Cancers Symposium

Biomarker development trial of satraplatin in patients with metastatic castrate-resistant prostate cancer.

Biomarker development trial of satraplatin in patients with metastatic castrate-resistant prostate cancer.

First Author: Bobby Chi-Hung Liaw